Clinical Trial Update: Randomized Phase II Study of DCE-MRI-based Dose Escalation for Poor-prognosis and Neck Cancer [Phase 2]

View source ↗

Summary

Randomized Phase II study evaluated DCE-MRI–guided dose escalation for poor-prognosis squamous cell carcinoma of the head and neck. The trial status is COMPLETE…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Squamous Cell Carcinoma of the Head and Neck

Snippet

Sponsor: University of Michigan Rogel Cancer Center | Conditions: Squamous Cell Carcinoma of the Head and Neck | Phase 2 | Status: COMPLETED | Results posted: 2026-03-02